Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lipopolysaccharide (LPS) core glycolipid is a central structural component of the outer membrane of Gram-negative bacteria. It forms part of the larger LPS molecule, linking lipid A to the O-antigen or terminating at the cell surface if the O-antigen is absent. The core oligosaccharide can be divided into two subregions: the inner core (highly conserved, containing Kdo and Hep) and the outer core (more variable, composed of hexoses). It provides structural integrity, acts as a permeability barrier, and plays a role in immune interactions and bacterial virulence. Variations in its structure influence antibiotic resistance, immunogenicity, and susceptibility to host defenses.
N/A (Structural component, not directly targeted by drugs in the same way as receptors or enzymes)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipopolysaccharide Core Glycolipid (LPS Core Glycolipid).